Literature DB >> 7586671

Accumulation of activated CD4+ lymphocytes in the lung of individuals infected with HIV accompanied by increased virus production in patients with secondary infections.

M Franchini1, C Walker, D R Henrard, D Suter-Gut, P Braun, B Villiger, M Suter.   

Abstract

The lung is continuously exposed to infectious and non-infectious agents causing cell activation. Activated cells in the lung such as antigen-presenting cells which harbour HIV may favour this organ as a site for virus production. To test this hypothesis, cells from blood and bronchoalveolar lavage (BAL) of HIV-infected patients and healthy controls were obtained and the activation of the cells were analysed by measuring the expression of IL-2 receptor, HLA-DR and VLA-1. The HIV-infected individuals were subdivided into 'lung symptomatic' or 'lung asymptomatic' patients, depending on the presence or absence of secondary lung diseases besides HIV. All HIV-infected individuals demonstrated a decreased number of CD4+ lymphocytes in blood; however, normal numbers of these cells were found in BAL. The activation state of CD4+ and CD8+ T lymphocytes in blood and BAL was higher in lymphocytes from HIV-infected patients compared with controls. The activation state was highest in the lung symptomatic group. Lung symptomatic patients and lung asymptomatic patients with extrapulmonary infections had increased levels of free virus in plasma. Four out of four individuals without or with only low amounts of cell-free HIV in plasma belonged to the symptom-free subgroup. These results suggest that microorganisms other than HIV may promote viral replication via antigen-driven accumulation and activation of CD4+ cells in the lung or other organs, and thus may be responsible for the loss of helper T cells and the progression of the disease.

Entities:  

Mesh:

Year:  1995        PMID: 7586671      PMCID: PMC1553413          DOI: 10.1111/j.1365-2249.1995.tb03770.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  38 in total

Review 1.  Technical recommendations and guidelines for bronchoalveolar lavage (BAL). Report of the European Society of Pneumology Task Group.

Authors: 
Journal:  Eur Respir J       Date:  1989-06       Impact factor: 16.671

2.  Extraction of immune and inflammatory cells from human lung parenchyma: evaluation of an enzymatic digestion procedure.

Authors:  P G Holt; B W Robinson; M Reid; U R Kees; A Warton; V H Dawson; A Rose; M Schon-Hegrad; J M Papadimitriou
Journal:  Clin Exp Immunol       Date:  1986-10       Impact factor: 4.330

3.  Isolation of HIV-1 from the blood of seropositive adults: patient stage of illness and sample inoculum size are major determinants of a positive culture. The Walter Reed Retroviral Research Group.

Authors:  D S Burke; A K Fowler; R R Redfield; S Dilworth; C N Oster
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1990

4.  Quantitation of human immunodeficiency virus type 1 in the blood of infected persons.

Authors:  D D Ho; T Moudgil; M Alam
Journal:  N Engl J Med       Date:  1989-12-14       Impact factor: 91.245

5.  Plasma viremia in human immunodeficiency virus infection.

Authors:  R W Coombs; A C Collier; J P Allain; B Nikora; M Leuther; G F Gjerset; L Corey
Journal:  N Engl J Med       Date:  1989-12-14       Impact factor: 91.245

6.  HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure.

Authors:  J A Zack; S J Arrigo; S R Weitsman; A S Go; A Haislip; I S Chen
Journal:  Cell       Date:  1990-04-20       Impact factor: 41.582

7.  AIDS virus-specific cytotoxic T lymphocytes in lung disorders.

Authors:  F Plata; B Autran; L P Martins; S Wain-Hobson; M Raphaël; C Mayaud; M Denis; J M Guillon; P Debré
Journal:  Nature       Date:  1987 Jul 23-29       Impact factor: 49.962

8.  A diffusible lymphokine produced by CD8+ T lymphocytes suppresses HIV replication.

Authors:  C M Walker; J A Levy
Journal:  Immunology       Date:  1989-04       Impact factor: 7.397

9.  The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1.

Authors:  J L Fahey; J M Taylor; R Detels; B Hofmann; R Melmed; P Nishanian; J V Giorgi
Journal:  N Engl J Med       Date:  1990-01-18       Impact factor: 91.245

10.  HIV-1 replication is controlled at the level of T cell activation and proviral integration.

Authors:  M Stevenson; T L Stanwick; M P Dempsey; C A Lamonica
Journal:  EMBO J       Date:  1990-05       Impact factor: 11.598

View more
  3 in total

Review 1.  Lung microbiome in human immunodeficiency virus infection.

Authors:  Homer L Twigg; George M Weinstock; Kenneth S Knox
Journal:  Transl Res       Date:  2016-07-18       Impact factor: 7.012

2.  Similar patterns of infection with bovine foamy virus in experimentally inoculated calves and sheep.

Authors:  Magdalena Materniak; Torsten Hechler; Martin Löchelt; Jacek Kuzmak
Journal:  J Virol       Date:  2013-01-16       Impact factor: 5.103

Review 3.  Impact of antiretroviral therapy on lung immunology and inflammation.

Authors:  Homer L Twigg; Kenneth S Knox
Journal:  Clin Chest Med       Date:  2013-04-08       Impact factor: 2.878

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.